Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy Barclays PLC

Vertex Pharmaceuticals Inc.
Start price
€394.15
27.01.26 / 50%
Target price
-
27.01.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 27.01.27. The prediction end date can be changed by Barclays_PLC at any time.
Performance without dividends (%)
Name 1w
Vertex Pharmaceuticals Inc. -
iShares Core DAX® 1.130%
iShares Nasdaq 100 1.128%
iShares Nikkei 225® 2.610%
iShares S&P 500 -0.006%

Comments by Barclays_PLC for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren

Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Ratings data for VRTX provided by MarketBeat

Barclays PLC 
0
Report Share
27.01.26 Buy -

Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€387.70
06.02.24
€439.24
06.02.25
19.98%
07.02.25

Barclays PLC 
06.02.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€327.60
11.12.23
€385.41
11.12.24
35.84%
12.12.24

Barclays PLC 
11.12.23 50%